Medtronic (NYSE: MDT) reported Q3 EPS of $1.29, $0.14 better than the analyst estimate of $1.15. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.78 billion.

Guidance:

Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is not providing formal annual or quarterly financial guidance at this time.

For earnings history and earnings-related data on Medtronic (MDT) click here.